BOLD-100 (NKP-1339; IT-139) freebase is a ruthenium-based anticancer agent; it inhibits stress-induced upregulation of GRP78, thereby disrupting endoplasmic reticulum (ER) homeostasis and inducing ER stress and the unfolded protein response (UPR); it also interferes with the complex interplay between ER stress response, lysosomal dynamics, and autophagy.